New Kardia™ Band for Apple Watch Delivers Medical-grade Electrocardiogram (EKG) Anytime, Anywhere
AliveCor Creates 'Wearable MedTech' Category and Extends Kardia Product Line
SAN FRANCISCO, March 16, 2016 /PRNewswire/ -- AliveCor, Inc., the leader in FDA-cleared electrocardiogram (EKG) technology for mobile devices, announced today the introduction of the first medical-grade EKG band for the Apple Watch, Kardia™ Band (pending 510k clearance, expected availability late spring) along with a new app for smartphones (available now). The Kardia Band for Apple Watch, and new Kardia app, represent a significant breakthrough in proactive heart health by allowing people to discretely capture their EKG anytime, anywhere.
Photo - http://photos.prnewswire.com/prnh/20160315/344734
Photo - http://photos.prnewswire.com/prnh/20160315/344744
Users can record a single-lead EKG by simply touching Kardia Band's integrated sensor that communicates with the Watch app, Kardia by AliveCor™. The Atrial Fibrillation (AF) Detector then uses Kardia's automated analysis process (algorithm) to instantly detect the presence of AF in an EKG, the most common cardiac arrhythmia and a leading cause of stroke. Also included is the Normal Detector, which indicates whether your heart rate and rhythm are normal, and the Unreadable Detector, which tells you when to retake an EKG so physicians receive only the highest quality recordings.
Users can also record voice memos on their Apple Watch to accompany each EKG that give doctors and caregivers a clearer picture of what was happening at the time of the recording — describing symptoms such as palpitations or external factors like caffeine intake. Kardia also integrates seamlessly with Apple's Health app to include EKG data with steps and calorie intake to provide richer, personal analysis over time.
"Kardia Band for Apple Watch represents both the future of proactive heart health and the introduction of the Wearable MedTech category," said Vic Gundotra, chief executive officer of AliveCor. "These combined technologies give us the ability to deliver personal reports that provide analysis, insights and actionable advice for the patient and their doctor."
"The personal, discrete Kardia Band is a perfect fit for Apple Watch. It allows patients to easily measure and record their heart rhythm in real time. This can provide patients with a sense of control—which is vitally important to successful patient engagement in the treatment of chronic disease," said Kevin R. Campbell, MD, FACC, North Carolina Heart and Vascular UNC Healthcare, clinical cardiac electrophysiology assistant professor, UNC Department of Medicine, Division of Cardiology, and President, K-Roc Consulting, LLC.
Kardia Band is designed for anyone who wants to learn more about their health in addition to people with AF, and doctors who want to bring the latest in proactive heart health technology to their patients and practices. Kardia Band provides caregivers the opportunity to take a more active role in helping their loved one engage in their own care. The Kardia Band is pending 510k clearance and is not currently for sale in the U.S.
AliveCor has re-introduced its first device, the AliveCor Mobile ECG, under the new Kardia brand name as Kardia™ Mobile. This change establishes a family of products and makes the name Kardia synonymous with proactive heart health. Currently, Kardia Mobile works with iPhone, iPad and iPod touch, and most Android OS. The new Kardia app is available now for download for iOS and Android users.
For more information on where to buy the Kardia Mobile, visit alivecor.com.
About AliveCor, Inc.
AliveCor, Inc. is pioneering the creation of FDA-cleared 'machine learning' techniques to enable proactive heart care and is recognized around the world for transforming cardiac care. The FDA-cleared Kardia Mobile is the most clinically validated mobile EKG solution on the market1 and is recommended by leading cardiologists and used by people worldwide for accurate EKG recordings. This simple to use mobile device and app-based service provides instant analysis for detecting atrial fibrillation (AF) and normal sinus rhythm in an EKG. AliveCor was recognized as a 2015 Tech Pioneer by the World Economic Forum and one of the 50 Smartest Companies in 2015 by the MIT Technology Review (#14). AliveCor is a privately-held company headquartered in San Francisco, Calif. For more information, please visit alivecor.com.
1Based on the number of published clinical studies using Kardia Mobile compared to other smartphone-based EKG devices.
AliveCor is a trademark of AliveCor, Inc., registered in the U.S. and other countries.
Media Contacts:
Rebecca Phillips
+1 (415) 795-9807
rebecca@alivecor.com
Kathi Johnson
+1 (310) 649-4781
kathleen@knjpr.com
Share this article